Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDG PET/CT: Reducing False Positive Mediastinal Uptake by Premedicating With Methylprednisolone

NCT01789892 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT01789892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01789892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDG PET/CT: Reducing False Positive Mediastinal Uptake by Premedicating With Methylprednisolone
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Withdrawn
Start date
June 30, 2011
Completion date
January 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer